Source: Virtual Congress 2021 – New insights into the airway immunology of lung disease



Rating:

Share or cite this content

Citations should be made in the following way:
I. Touil (MAHDIA, Tunisia), H. BAILI (MAHDIA, Tunisia), Y. Brahem (MAHDIA, Tunisia), S. Bouchareb (MAHDIA, Tunisia), N. Keskes Boudawra (MAHDIA, Tunisia), S. Kessisa (MAHDIA, Tunisia), J. Ayeb (MAHDIA, Tunisia), J. Knani (MAHDIA, Tunisia), L. Boussoffara (MAHDIA, Tunisia). Neutrophil to lymphocyte ratio and severity of COPD : prospective study. 689

Member's Comments

No comment yet.

Related content which might interest you: The prognosis of the neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in lung cancer and the association with treatment: a retrospective study> Source: International Congress 2017 – Lung cancer - clinical research: scientific pearls from the bedside Year: 2017 Neutrophil-to-lymphocyte ratio, blood eosinophils and COPD exacerbations: a cohort study Source: ERJ Open Res, 7 (4) 00471-2021; 10.1183/23120541.00471-2021 Year: 2021 Circulating eosinophil levels do not predict severe exacerbations in COPD: a retrospective study Source: ERJ Open Res, 4 (3) 00022-2018; 10.1183/23120541.00022-2018 Year: 2018 Significance of neutrophil to lymphocyte ratio in patients of chronic obstructive pulmonary diseases: A prospective study at tertiary care centre in India Source: International Congress 2015 – Monitoring and phenotyping COPD Year: 2015 Neutrophil to lymphocyte ratio and clinical outcomes in COPD: recent evidence and future perspectives Source: Eur Respir Rev, 27 (147) 170113; 10.1183/16000617.0113-2017 Year: 2018 Importance of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in COPD exacerbations Source: International Congress 2017 – COPD and weaning Year: 2017 Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in patients with acute exacerbation of chronic obstructive pulmonary disease Source: International Congress 2018 – Biomarkers for evaluating COPD Year: 2018 LSC - 2019 - Assessment of platelet to lymphocyte ratio and neutrophil to lymphocyte ratio as biomarkers of steroid resistance in patients with COPD Source: International Congress 2019 – Novel molecular pathways in lung cancer and COPD Year: 2019 Association between admission neutrophil to lymphocyte ratio and outcomes in patients with acute exacerbation of COPD. Source: International Congress 2017 – Highlights on clinical problems in COPD Year: 2017 Could eosinophil / neutrophil ratio be used to determine treatment in COPD patients? Source: International Congress 2018 – Biomarkers for evaluating COPD Year: 2018 Predictors of lung function decline: a retrospective study in COPD patients Source: International Congress 2018 – COPD exacerbations and bronchiectasis Year: 2018 1-year prospective study in severe COPD patients: marker of inflammation, lung function and radiologic evaluation Source: Annual Congress 2007 - Pathophysiology and assessment of COPD Year: 2007 Relationship between blood eosinophil count (Eos), clinical characteristics and mortality of patients with COPD Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016 Eosinophil counts as a predictor of future COPD exacerbations in the DYNAGITO trial Source: International Congress 2019 – Eosinophils and FeNO in airway diseases Year: 2019 Eosinophil count on admission is not a good biomarker in severe exacerbations of COPD to predic later readmission: a long term observational study from the AECOPD-Barcelona Cohort Source: International Congress 2018 – Biomarkers for evaluating COPD Year: 2018 D-dimer as a predictor of persistent pulmonary function impairment after COVID-19 pneumonia: a prospective observational study Source: Virtual Congress 2021 – Developments in biomarkers and treatment strategies for chronic lung diseases Year: 2021 Cilomilast reduces CD8+ T-lymphocytes and macrophages in patients with chronic obstructive pulmonary disease (COPD): a double-blind placebo-controlled, parallel-group quantitative study of bronchial biopsies Source: Eur Respir J 2001; 18: Suppl. 33, 338s Year: 2001 Statins and mortality in COPD in the COMIC study: A prospective COPD cohort study Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016 Bacterial infection in hospitalized patients of acute exacerbation of COPD and their relation to lung function: A prospective study Source: International Congress 2016 – Clinical and microbiological aspects of infections in COPD patients Year: 2016 COPD and its comorbidities – prospective study Source: Eur Respir J 2007; 30: Suppl. 51, 79s Year: 2007